Canonical Thrombopoietin Receptor Mutants in Myeloproliferative Neoplasms Rely Differently on the Extracellular Domain of the Receptor but Share Similar Mechanisms of Inactivation: An Open Field for the Development of New Therapies

Authors :: Gabriel Levy
Nicolas Papadopoulos
Christian Pecquet
Jean-Philippe Defour
Emilie Leroy
Nabih Maslah
Bruno Cassinat
Steven Smith
Stefan N Constantinescu
Source :: Blood. 140:8736-8737
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools